Skip to content

Study to evaluate safety and performance of nice Neotechâ??s Bubble CPAP System in treating newborn respiratory distress syndrome (RDS)

An Open label Single center Prospective Observational study to evaluate the safety and performance of nice Neotechâ??s Bubble CPAP System on new-born babies suffering from respiratory distress syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042207
Enrollment
70
Registered
2022-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P220- Respiratory distress syndrome of newborn

Interventions

None listed

Sponsors

nice Neotech Medical Systems Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Subjects with Parental informed consent. -Subjects indicated for Respiratory support using Bubble CPAP -Subject with Respiratory Distress Syndrome related to prematurity -Subject with Gestational age Subjects may be in-born (at the study site) or out-born (born at another hospital and transferred within the first 24 hours)

Exclusion criteria

Exclusion criteria: -Lack of Parental / Informed consent -Subjects with known congenital anomalies necessitating intubation -Genetic anomalies, Congenital Heart Defects (not including PDAs, small ASDs, small VSDs) -Prenatally diagnosed pulmonary hypoplasia -Subjects with perinatal asphyxiation, sepsis or severe hemodynamic instability Subjects presenting with any contraindications to Bubble CPAP therapy (or indications for mechanical ventilation) within the first 24 hours of life will be excluded from participation including: apnea (defined as >= 8 episodes within 24 hours or any episode with accompanied bradycardia) or poor spontaneous respiratory effort, shock, massive pulmonary hemorrhage, severe metabolic acidosis (pH -10), severe respiratory acidosis (pH 55mmHg).

Design outcomes

Primary

MeasureTime frame
Weaned off Bubble CPAP / intubation followed by recovery and discharge/ intubation followed by deterioration and death / other.Timepoint: At the end of treatment.

Secondary

MeasureTime frame
Observation of any unexpected adverse events happenedTimepoint: At the end of treatment.

Countries

India

Contacts

Public ContactBalasubramani

nice Neotech Medical Systems Pvt. Ltd.

bala@niceneotech.com9551896959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026